Skip to main content
COR
NYSE Life Sciences

Cencora Appoints Eva Boratto as New CFO, Reaffirms FY26 EPS Guidance

Reported by dpa-AFX
Sentiment info
Neutral
Importance info
7
Price
$271.24
Mkt Cap
$52.683B
52W Low
$244.82
52W High
$377.54
Market data snapshot near publication time

Summary

Cencora has appointed Eva Boratto as its new Executive Vice President and Chief Financial Officer, effective June 29, 2026. This follows the company's March 17th announcement of the planned retirement of the previous CFO, James Cleary. Boratto brings experience from Bath & Body Works, where she led a multi-year transformation strategy. The company also reaffirmed its fiscal year 2026 adjusted diluted EPS guidance range of $17.70 to $17.90, which was recently raised on May 21st. This news provides clarity on key leadership and confirms the company's financial outlook.

At the time of this announcement, COR was trading at $271.24 on NYSE in the Life Sciences sector, with a market capitalization of approximately $52.7B. The 52-week trading range was $244.82 to $377.54. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: dpa-AFX.


Price Chart

Share this article

Copied!

COR - Latest Insights

COR
May 27, 2026, 8:01 AM EDT
Source: dpa-AFX
Importance Score:
7
COR
May 21, 2026, 5:11 PM EDT
Source: Reuters
Importance Score:
8
COR
May 21, 2026, 4:32 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
COR
May 06, 2026, 2:41 PM EDT
Filing Type: 10-Q
Importance Score:
7
COR
May 06, 2026, 7:39 AM EDT
Source: Reuters
Importance Score:
8
COR
May 06, 2026, 6:32 AM EDT
Filing Type: 8-K
Importance Score:
8
COR
Mar 23, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
COR
Mar 23, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
COR
Mar 17, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
7
COR
Feb 18, 2026, 7:34 AM EST
Filing Type: 8-K
Importance Score:
9